Protein and energy metabolism in chronic bacterial infection: studies in melioidosis

Nicholas I. Paton(St George's Hospital), George E. Griffin(St George's Hospital), E. Milne(University of Aberdeen), Yupin Suputtamongkol(Mahidol University), Wipada Chaowagul(Sappasithiprasong Hospital), Andrew J. H. Simpson(University of Hull), Graham Calder(University of Aberdeen), Nicholas J. White(Angkor Hospital for Children), M. Elia(Unité de Nutrition Humaine), Brian Angus(University of Oxford)
Clinical Science
December 13, 2000
10.1042/cs1000101
Cited by 15

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18
|Nature|2001|1.3k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Typhoid Fever
|New England Journal of Medicine|2002|1.1k